Association between single nucleotide variants of vascular endothelial growth factor A and the risk of thyroid carcinoma and nodular goiter in a Han Chinese population.
The aim of the present study was to investigate whether genetic variants in the vascular endothelial growth factor A gene (VEGFA) were risk factors for papillary thyroid carcinoma (PTC) or nodular goiter (NG) in Han Chinese. A total of 2,319 subjects (861 PTC patients, 562 NG patients, and 896 healthy controls) were included. Five tag single nucleotide polymorphisms (tagSNPs: rs3024997, rs3025040, rs833070, rs25648, and rs10434) in VEGFA were genotyped. SNP rs3025040 T allele was associated with a decreased risk of NG (P<0.05). SNP rs3024997 was associated with an increased risk of PTC (P<0.05) and NG (P<0.001) when an over-dominant model (AA+GG vs. AG) was considered. PTC patients carry the less frequent TT genotype (compared to the CC genotype) (P <0.05) of SNP rs3025040. Likewise, NG patients have the less frequent TC genotype compared to the CC (P <0.05). No significant association of SNPs rs833070, rs25648, and rs10434 with PTC or NG was observed. Haplotypes AT (rs3024997 and rs3025040) and GTA (rs10434, rs3025040, and rs3024997) showed a lower risk for NG (P <0.01 and P <0.05, respectively), while haplotypes GTT (rs833070, rs3025040, and rs3024997) and GGGT (rs833070, rs10434, rs3024997, and rs3025040) predicted the risk of progression to NG (both P <0.05). Haplotype AGAC (rs833070, rs10434, rs3024997, and rs3025040) conferred protection for PTC (P <0.05). In summary, this study indicated for the first time that SNPs rs3024997 and rs3025040 in VEGFA were significantly associated with PTC and/or NG. Haplotypes of the VEGFA may influence the risk of PTC and NG.
Department of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun 130021, China.
Rui
R
Liu
Department of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun 130021, China.|National Research Institute for Family Planning, Beijing 100081, China.
Lifeng
L
Ning
Jilin Provincial Key Laboratory of Surgical Translational Medicine, China-Japan Union Hospital, Jilin University, Changchun 130033, China.
Xiaoli
X
Liu
Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06511, USA.
Huiping
H
Zhang
Department of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun 130021, China.
Yaqin
Y
Yu
Department of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun 130021, China.
Shangchao
S
Zhang
Department of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun 130021, China.
Wenwang
W
Rao
Department of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun 130021, China.
Jieping
J
Shi
Jilin Provincial Key Laboratory of Surgical Translational Medicine, China-Japan Union Hospital, Jilin University, Changchun 130033, China.
Hui
H
Sun
Department of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun 130021, China.
Qiong
Q
Yu
D000328:Adult; D044466:Asian People; D005260:Female; D006044:Goiter, Nodular / Q000235:genetics*; D006801:Humans; D008297:Male; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D012307:Risk Factors; D013964:Thyroid Neoplasms / Q000235:genetics*; D042461:Vascular Endothelial Growth Factor A / Q000235:genetics*
D042461:Vascular Endothelial Growth Factor A
Han Chinese; SNPs; VEGFA; nodular goiter; papillary thyroid carcinoma